Hotel analytics firm STR and travel data company Tourism Economics once again have downgraded their U.S. hotel forecast for 2025 and 2026 due to what they characterized as a static macroeconomic ...

PETALING JAYA: The government will bring forward the Phase 4 payments for the Sumbangan Tunai Rahmah (STR) 2025 to Oct 18, ahead of Deepavali. In a statement on Friday (Oct 17), the Finance Ministry ...

The buzz is real! The much-awaited partnership between Silambarasan and Vetri Maaran has finally been unveiled under the name 'Arasan'. This cinematic gem, set in the Vada Chennai narrative, showcases ...

As of September 30, 2025, the average one-year price target for Inter is $8.45/share. The forecasts range from a low of $4.44 to a high of $10.29. The average price target represents a decrease of ...

The GI tract is a complex group of organs, each of which helps your body digest and absorb food. Your upper GI tract includes your esophagus, stomach, and the first section of your small intestine, ...

Inter & Co. Inc. (INTR) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue ...

Inter & Co. Inc. (INTR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Appendix cancer, also called appendiceal cancer, is when abnormal cells grow and form a tumor in the appendix. Your appendix is a little pouch-like organ attached to the lower right side of your large ...

PUTRAJAYA: The government will begin disbursing payments for the Phase Three Rahmah Cash Contribution (STR) starting Tuesday (Aug 12), allocating RM2bil to ease the cost of living for low-income ...

Brazilian digital bank Inter & Co. achieved massive customer growth amid a booming fintech industry in Latin America while showing improvements in its key operating metrics. While facing intense ...

Appendix cancer has traditionally been thought of as a very rare diagnosis, usually occurring in patients in their 40s or 50s. But doctors are increasingly seeing a disturbing trend: cases, most ...

For the first time a major study aims to get a better understanding of the biology of a rare appendix cancer and dramatically delay recurrence. Pseudomyxoma peritonei, or PMP, affects up to 400 new ...